Momenta Pharm. (Cambridge, MA) and its exclusive licensee Sandoz, Inc. (Princeton, NJ) have sued Teva Pharm. Indus. Ltd. (Petach Tikva, Israel) and Teva Pharm. USA (North Wales, PA) for infringement of Patent Nos. 7,575,886 and 7,790,466 directed to ways of manufacturing generic enoxaparin.
The complaint is based on a series of actions and statements on the part of Teva that suggest it has either infringed or is about to start infringing. To cover their bases, the plaintiffs include in the complaint not only counts for infringement but also counts for declarations of infringement.
Momenta Pharm., Inc. v. Teva Pharm. Indus. Ltd., 10-12079-RBC (D. Mass. Dec. 2, 2010)
Comments